Leukemia Therapeutics Market Set to Revolutionize the Industry with Emerging Tech by 2032
The global leukemia therapeutics market, valued at USD 16.63 billion in 2024, is poised for substantial expansion, driven by the increasing incidence of various types of leukemia worldwide, coupled with significant advancements in treatment modalities, particularly targeted therapies and immunotherapies. Projections indicate a climb from USD 17.68